Ryght's LinkedIn Live session uncovers the forefront of industry trends on the transformative potential of generative AI and its profound impact on shaping tomorrow's medical landscape.
Simon Arkell, Ryght's Co-Founder & CEO, is joined by Tom Pike, Chairman & CEO of Fortrea, who brings over 30 years of leadership in global services industries, including significant roles in the contract research organization (CRO) sector, spanning pharmaceuticals, biotech, hospitals, and global sites.
The session explores how generative AI fosters strategic partnerships to overcome pivotal challenges in clinical development. Arkell and Pike discuss how technology plays a huge role from seamless data integration and operational efficiency to ensuring diversity in clinical trials, driving meaningful advancements in healthcare through innovation and collaboration.
About Ryght
Ryght is a privately held healthcare technology company based in Anaheim, California that is developing the next generation of safe and secure generative artificial intelligence (GenAI) solutions for the biopharma industry. The Ryght platform leverages and optimizes multiple large language models (LLMs) and vector databases to ingest real-time data streams and make actionable knowledge directly available to biopharma discovery, clinical, and commercial teams. The platform enables healthcare professionals to rapidly leverage the power of GenAI within compliance of data security standards required by the industry.
Follow the company on 